Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms-Reference-Cited by-同舟云学术

Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms

Published:2019-10-31 Issue:22 Volume:62 Page:10305-10320
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yang Tao¹,Hu Mengshi¹,Qi Wenyan¹,Yang Zhuang¹,Tang Minghai¹,He Jun¹,Chen Yong¹,Bai Peng¹,Yuan Xue¹,Zhang Chufeng¹,Liu Kongjun¹,Lu Yulin¹,Xiang Mingli¹,Chen Lijuan¹^ORCID

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China

Funder

National Natural Science Foundation of China

1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b01348

Reference45 articles.

1. Jaks and Stats in signaling by the cytokine receptor superfamily

2. TheJanusprotein tyrosine kinases in hematopoietic cytokine signaling